Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Yervoy
Yervoy
Bristol-Myers Skin-Cancer Drug Yervoy Rejected by U.K. Health Cost Agency
Bloomberg
Fri, 10/14/11 - 11:23 am
UK
Yervoy
Bristol-Myers Squibb
NICE
skin cancer
Yervoy may face Roche rival sooner than expected
Fierce Pharma
Tue, 08/9/11 - 06:29 pm
Bristol-Myers Squibb
Zelboraf
melanoma
Yervoy
Roche
Yervoy hits the market with $95M bang
Fierce Pharma
Fri, 07/29/11 - 09:44 am
Yervoy
Bristol-Myers Squibb
melanoma
As Dapagliflozin Receives Negative Vote, What's Next for Bristol Myers?
Seeking Alpha
Thu, 07/21/11 - 10:57 am
Bristol-Myers Squibb
Dapagliflozin
Pfizer
Eli Lilly
AstraZeneca
JNJ
Yervoy
Second Phase 3 Study of YERVOY™ (ipilimumab) in Metastatic Melanoma Meets Primary Endpoint of Overall Survival
Yahoo/BusinessWire
Sun, 06/5/11 - 10:45 am
Yervoy
Bristol-Myers Squibb
melanoma
Roche, Bristol Melanoma Drugs Shine
The Street
Sun, 06/5/11 - 10:39 am
Roche
Bristol-Myers Squibb
melanoma
vemurafenib
Yervoy
Bristol-Myers, Roche team up on melanoma drugs
Yahoo/AP
Thu, 06/2/11 - 10:26 am
Roche
Bristol-Myers Squibb
melanoma
Yervoy
vermurafenib
Melanoma Set to Be a Hot Topic at ASCO
WSJ Online
Wed, 06/1/11 - 12:35 pm
ASCO
melanoma
skin cancer
Yervoy
Bristol-Myers Squibb
Daiichi Sankyo
Roche
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Wed, 05/25/11 - 09:28 am
Roche
skin cancer
melanoma
vemurafenib
GSK
Bristol-Myers Squibb
Daiichi Sankyo
Yervoy
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Sat, 05/21/11 - 11:05 am
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Bristol-Myers' Yervoy and Dendreon's Provenge: Similarities Between First Two Active Immunotherapies in Cancer
Minyanville
Wed, 03/30/11 - 11:24 am
Yervoy
Provenge
Dendreon
Bristol-Myers Squibb
melanoma
prostate cancer
Bristol-Myers Squibb: Ipilimumab Approval Brings Positive Surprises
Seeking Alpha
Tue, 03/29/11 - 08:27 am
ipilimumab
Bristol-Myers Squibb
Yervoy
Is Approval of Bristol-Myers Squibb's Yervoy Start of New Chapter at FDA?
Minyanville
Mon, 03/28/11 - 09:48 am
FDA
Bristol-Myers Squibb
Yervoy
ipilimumab
melanoma
Ipilimumab Approval Highlights Active Immunotherapy Renaissance
Seeking Alpha
Sun, 03/27/11 - 11:39 am
ipilimumab
monoclonal antibodies
immunotherapy
Yervoy
Bristol-Myers Squibb
melanoma
[video] The Next Big Thing In Biotech: Bristol-Myers
TheStreet.com
Fri, 03/18/11 - 09:01 am
Bristol-Myers Squibb
skin cancer
Yervoy
ipilimumab
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Pages
« first
‹ previous
1
2
3
4
5
6
7